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the role of our gut microbiota in health and disease is largely attributed to the collective metabolic 
activities of the inhabitant microbes. a system-level framework of the microbial community structure, 
mediated through metabolite transport, would provide important insights into the complex microbe-
microbe and host-microbe chemical interactions. this framework, if adaptable to both mouse and 
human systems, would be useful for mechanistic interpretations of the vast amounts of experimental 
data from gut microbiomes in murine animal models, whether humanized or not. Here, we constructed 
a literature-curated, interspecies network of the mammalian gut microbiota for mouse and human 
hosts, called NJC19. This network is an extensive data resource, encompassing 838 microbial species 
(766 bacteria, 53 archaea, and 19 eukaryotes) and 6 host cell types, interacting through 8,224 small-
molecule transport and macromolecule degradation events. Moreover, we compiled 912 negative 
associations between organisms and metabolic compounds that are not transportable or degradable 
by those organisms. Our network may facilitate experimental and computational endeavors for the 
mechanistic investigations of host-associated microbial communities.
Background & Summary
The mammalian intestinal tract is colonized by various microorganisms, called the gut microbiota or microbi-
ome1–3. Recent advances in metagenomics have revealed that alterations in the human gut microbiota are impli-
cated in a number of disorders, such as obesity, inflammatory bowel disease, colorectal cancer, and diabetes4–7. At 
the center of the gut microbiota functions are the various interactions between microbes and their interplay with 
the host environment2,6,8. Microbes degrade diet-derived and host-derived chemical substances, and release the 
degradation products to other members of the community. The microbial transport of nutrients and metabolic 
byproducts gives rise to competition for resources and cooperative relationships via metabolic cross-feeding2,8. 
The metabolites secreted by the microbes are absorbed by host tissues, and translate into beneficial or detrimental 
mediators of host physiology6,9. As a result, such microbe-microbe and microbe-host interactions form a complex 
ecological network in the gut environment10.
In the microbiome research, one common practice for reconstructing metabolite-mediated microbial net-
works is to combine the entire biochemical reactions inferred from annotated metagenomes11,12. This method, 
by its nature, does not delineate biochemical reactions to the species from which they originate, making it dif-
ficult to elucidate interspecies interactions. On the other hand, there exist previous works on the modeling of 
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diverse interspecies interactions explicitly mediated by metabolites that are transported (imported or exported) 
by individual microbial species13,14. Yet, these works are based on error-prone, automated identification proto-
cols for transportable metabolites, which are possibly inaccurate to some degrees. There are ongoing computa-
tional efforts towards biologically realistic microbial interactions, by using manually curated, constraint-based 
metabolic models or relatively simple kinetic models15,16. Nevertheless, most of these models are far from the 
scale of diversity seen in the gut community, which typically comprises hundreds of different microbial species. 
Notably, this scale of microbial diversity has been recently captured by constraint-based metabolic models with 
semi-automatic model reconstructions17, but they still exhibit limited biological accuracies18–20.
Recently, we have constructed an extensive, literature-curated interspecies metabolic interaction network of 
the human gut microbiota, NJS16, which represents another system-level framework for gut microbiota analy-
sis10. This network is primarily based on biological knowledge and experimental evidence documented in the 
literature. The network NJS16 encompasses >4,000 small-molecule transport and macromolecule degradation 
events of >500 bacterial and archaeal species and 3 human cell types. Although NJS16 is useful to explore the 
microbial community inside the human gut, mechanistic studies in the microbiome research field have been 
mainly conducted on animal models, rather than on human subjects, due to the technical and regulatory limita-
tions on human experimentation21,22. Regarding animal models, physiological, anatomical, and genetic similar-
ities between humans and mice, as well as massively accumulated knowledge of mouse genetics, have facilitated 
the use of murine models, to elucidate causality and mechanisms of host-microbiota interactions4,7,23. In this 
regard, a phylogenetic extension of NJS16 to murine gut microbes would be useful for the system-level mechanis-
tic exploration of gut microbiota functions using murine animal models.
Here, we present a literature-curated, interspecies metabolic interaction network of the microbiota associated 
with the mouse and human gut, NJC19. To our knowledge, NJC19 represents the largest ever, literature-based 
network data resource for the mammalian gut microbiota, as a compilation of information from 769 research and 
review articles and textbooks (Fig. 1). This network is an advancement from our previous network, NJS16, which 
is limited to the human gut microbiota10. Specifically, NJC19 greatly expands the diversity of microbial species 
and host cells to those relevant to the mouse gut environments, and even covers a certain range of eukaryotic 
microbes that were completely missing in the predecessor NJS16. Therefore, NJC19 serves as a global network 
template, adaptable to the gut microbiota of either a mouse, human, or humanized mouse. Moreover, not only 
does NJC19 incorporate metabolite transport and macromolecule degradation events of the microbiota, but it 
also provides literature-annotated, negative information of which metabolic compounds are not able to be trans-
ported or degraded by the organisms. Such negative information would be useful to curate computational micro-
bial models, such as constraint-based metabolic models, which can include false-positive transport reactions 
from automatic genome annotations.
We expect our network NJC19 to be a useful template for the mechanistic interpretation of various microbi-
ome data from murine and human experiments.
Mammalian gut microbiota metabolic 
transport network (NJC19)
838 microbial species (bacteria, archaea, eukaryotes)
3 mouse and 3 human cell types
283 metabolic compounds
8,224 metabolic transport and degradation events
912 negative metabolic associations
323 microbial species, 3 host cell types
202 metabolic compounds
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Fig. 1 Construction of the mammalian (mouse and human) gut microbiota interaction network NJC19. The 
flow chart of the network construction is presented. NJC19 is mainly built upon literature-curated, metabolic 
information of the mouse gut microbiota, combined with the revised version of NJS16 that represents the 
human gut microbiota interaction network.
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Methods
Collection of mouse microbiome data and taxonomic identification for NJC19 construction. 
We aimed to construct a large-scale network for the mammalian gut microbiota that comprises microbial species 
populating the mouse and human gut. Figure 1 provides the overview of our network construction procedure. 
To construct the network, we started by collecting raw shotgun metagenome and 16S rRNA gene sequence data 
from fecal and cecal samples of laboratory and wild-caught mice from seven different studies3,24–29, as detailed in 
Online-only Table 1. It is noteworthy that the inclusion of the data from wild-caught mice3 allows the coverage of 
diverse microbial communities associated with natural murine lifestyles. The species-level taxonomic profiling 
of the shotgun metagenome sequence data was performed using the MetaPhlAn v2.0 software, which utilizes 
clade-specific marker sequences to identify microbial taxa30. When using MetaPhlAn v2.0, the “sensitive-local” 
mapping option was selected. For the taxonomic profiling of 16S rRNA gene sequence data, we used the open-ref-
erence OTU picking workflow of QIIME v1.8.0 with Greengenes v13_8_pp reference files31, and then selected 
species-level microbial taxa from the results. Among all species detected from the metagenome and 16S rRNA 
gene sequence data, priority for the collection of metabolic information (see below) was given to species absent in 
our previous network, NJS1610. In the case of the metagenome sequence data, the number of the detected species 
was rather excessive for our further processing; therefore, among those species, we only considered the species 
inhabiting ≥90% of the metagenome samples (with the relative abundance ≥0.001%) in each study. We found 
that the genera of these selected species account for the vast majority [89.6 ± 4.3% (avg. ± s.d.)] of the total micro-
bial abundances in the metagenome samples. In addition, we manually considered some relevant species, such as 
Citrobacter rodentium32 (Online-only Table 2–3).
Collection and integration of metabolic information for NJC19 construction. Using the reper-
toire of the aforementioned microbial species, metabolic information primarily collected for NJC19 construction 
was direct experimental evidence of the import and export of small-molecule metabolites (e.g., sugars, vita-
mins, organic acids, and gases) and the degradation of macromolecules (e.g., starch, cellulose, hemicellulose, and 
mucin), reported in literature. For the small-molecule metabolites, we mostly considered primary metabolites, 
i.e., nutrients and metabolic byproducts associated with microbial growth or reproduction. In addition, litera-
ture sources that report the mRNA or protein expression for metabolite-specific enzymes or transporters were 
considered. When encountering the information of which chemical compounds are not able to be transported 
or degraded by a given organism, we recorded this negative information as well, as part of our collected data. 
Despite technically not being a part of the gut microbiota, some host cells directly affect or are affected by micro-
bial metabolism, and thus were considered to be a functional extension of the microbial community. In a similar 
fashion to our previous network NJS16 for the human case, the specific mouse tissue cells that we considered were 
the intestinal absorptive cell, the mucin-secreting goblet cell, and the bile acid-secreting hepatocyte. Although 
the hepatocyte is not part of intestinal tissue, its secreted bile acids are utilized by microbes in the gut. In the case 
of the mouse intestinal absorptive cell, the information from a manually-curated, genome-scale metabolic model 
(iSS1393) was adopted33. All annotated metabolite transport or macromolecule degradation processes for differ-
ent strains of the same species were consolidated for that species as its collective feature. Because degradation of a 
given macromolecule is often performed by multiple species in the gut, we considered the corresponding degra-
dation products to be indirect export products of all species participating in that macromolecule degradation. In 
this work, we differentiated two macromolecules, xylan and mannan, from a “hemicellulose” macromolecule in 
NJS16, for more specific representation of their degradation products.
In parallel, we carefully re-examined the existing components of NJS1610,34, and removed the 
incorrectly-placed components and added new links found from literature, according to more specific and 
accurate information. The revised NJS16 was finally connected to the above mouse gut microbiota interac-
tion network through the common chemical compounds shared by the both networks, to form the mouse and 
human gut microbiota interaction network, NJC19 (Fig. 1 and Table 1). NJC19 is provided in both human- and 
machine-readable forms, through Online-only Tables 1–5(XLSX files) and JavaScript Object Notation (JSON) 
files deposited in the Dryad Digital Repository35, respectively. In addition, the Cytoscape Session (cys) file of 
NJC19 is provided for interactive network visualization35.
Data Records
Our network NJC19 offers the reference map of the mammalian gut microbiota and chemical compound rela-
tionships (from 769 literature sources), which can be adapted for each context of mouse, human, and humanized 
mouse microbiomes. In NJC19, one set of nodes corresponds to organisms (i.e., microbial species and host cells), 
while the other set corresponds to chemical compounds (i.e., small-molecule metabolites or macromolecules). 
An organism and a chemical compound are connected if the organism imports, exports, or degrades the chemical 
compound. NJC19 comprises 838 microbial species (766 bacteria, 53 archaea, and 19 eukaryotes) in the mouse 
and human gut, 6 mouse and human cell types metabolically interacting with those microbes, and 283 chemical 
compounds (266 small molecules and 17 macromolecules)—all interconnected by 8,224 small-molecule trans-
port or macromolecule degradation events. In addition, NJC19 provides information on small molecules and 
macromolecules that are reportedly not transportable or degradable by certain organisms—described through 
912 negative metabolic associations. These negative associations can be particularly useful for the curation of 
automatically-generated metabolic models, which may include false-positive transport reactions derived from 
inaccurate genome annotations.
Figure 2a shows the overall phylogenetic composition of microbial species included in NJC19. To overview 
the network topology of NJC19, we counted the number of metabolites imported or exported by each microbial 
species. Each species in the network imports 5.8 and exports 3.5 metabolites on average, and the probability that 
a given species imports (or exports) k metabolites follows an exponential distribution P(k) ∝ e−rk (r ≈ 0.2 and 
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0.3 for the import and export cases, respectively; see Fig. 2b,c). Bacteroides thetaiotaomicron is one of the most 
promiscuous species, importing 33 and exporting 29 metabolites. Conversely, for each metabolite, we counted 
the number of species importing or exporting that metabolite. The probability that a given metabolite is imported 
(or exported) by k species follows a power-law distribution P(k) ∝ k−γ (γ ≈ 1.4 for both import and export cases; 
Fig. 2d,e), which is much broader than the above exponential distributions. Among metabolites, glucose and ace-
tate are the most frequent substrate and product, respectively, and are imported by 303 species (36.2% of the total 
species) and exported by 461 species (55.0% of the total species). In contrast, an average metabolite is imported 
by 21.8 species and exported by 13.0 species. Collectively, metabolites are highly uneven in terms of the ranges of 
their transporting species.
As noted above, the full details of NJC19 are available in both human- and machine-readable forms, through 
Online-only Table 1 and JSON files in the Dryad Digital Repository35, respectively. As noted above, the cys file of 
NJC19 is available for network visualization35, and can be accessed by Cytoscape v3.7.236.
Online-only Table 1 shows the detailed sources of mouse metagenome and 16S rRNA gene sequence data 
that were used for microbial species identification when we constructed NJC19. Online-only Table 2 shows the 
literature sources of metabolic information used for NJC19 construction. Online-only Table 3 shows the list of 
microbial species and host cell types in NJC19. The name of each microbial species is presented with the NCBI 
taxonomy ID. Online-only Table 4 includes the list of small-molecule metabolites and macromolecules in NJC19. 
The name of each compound is presented with the KEGG compound ID. Supplementary Table 1 provides all 
the metabolic associations between chemical compounds and microbial species/host cells in NJC19, along with 
their literature sources. These metabolic associations include both positive and negative associations (see above). 
Online-only Table 5 shows the degradation products of macromolecules in NJC19.
On the other hand, our JSON files35 include “NJC19_network.json”, “NJC19_organism.json”, “NJC19_com-
pound.json”, and “NJC19_reference.json”. Among them, “NJC19_network.json” is equivalent to in Supplementary 
Table 1, in terms of its contents. This file consists of a total of 9,136 items. Each object in the file is exactly matched 
with one association in Supplementary Table 1. Each object has its own identification number that starts with 
“NJC19_” followed by a five-digit number. The object includes four key-value pairs. The keys are “Species”, 
“Small-molecule metabolite or macromolecule”, “Metabolic activity”, and “Ref. #”, reminiscent of the column 
names in Supplementary Table 1. The other files “NJC19_organism.json”, “NJC19_compound.json”, and “NJC19_
reference.json” include detailed information on the values of the keys “Species”, “Small-molecule metabolite or 
macromolecule”, and “Ref. #” in the file “NJC19_network.json”, respectively. In a similar fashion to Online-only 
Tables 3 and 4, each microbial species in “NJC19_organism.json” is annotated with the NCBI taxonomy ID, and 
each compound in “NJC19_compound.json” is annotated with the KEGG compound ID. Furthermore, the spe-
cific sample sources of these microbial species are also present in “NJC19_organism.json”. Full metadata of these 
JSON files are provided in another file “README_NJC19.txt”, which is available in the Dryad Digital Repository 
together with the JSON files35.
As described in Methods, our NJC19 construction was started with taxonomic identification of mouse gut 
microbiome samples. The comprehensive repertoire of those microbial taxa, identified before the collection of 
their metabolic information, is provided in the Dryad Digital Repository35 (Table 1). In the case of the metagen-
ome samples, it also provides the list of the selected species based on the frequency of their occurrence across the 
samples (Methods).
technical Validation
Metabolic information collected in this study was primarily experimental evidence of small molecule trans-
port and macromolecule degradation events, reported in the literature. Given the information dispersed across 
research papers, review articles, and textbooks (Online-only Table 2), a careful read of these sources was done to 
distinguish experimentally-verified information from the predictions solely based on automated bioinformatics 
algorithms. To check the accuracy of our network, the entire individual links in the compiled network were thor-
oughly re-examined by the independent authors who had not participated in the initial construction of the net-
work. If potential errors were identified from the examined links (e.g., errors from the possible misinterpretations 
of the literature), these errors were carefully corrected based on the discussion of multiple authors.
To further assess the validity of our network, we examined the correlations between microbe-metabolite links in the 
network and measured metabolite levels in the mouse gut and portal vein plasma. Specifically, we examined whether 
Source Processing Data
Mouse fecal and cecal microbiome data 
(Online-only Table 1).
Application of taxonomic analysis tools to the 
microbiome data (Methods).
Output flies of the taxonomic analysis tools, 
which include the lists of identified microbial 
taxa and their relative abundances35.
Lists of identified microbial taxa and their 
relative abundances from mouse fecal and 
cecal microbiome data35.
Selection of microbial species in metagenome 
samples based on the frequency of the species 
occurrence across the samples (Methods).
List of selected microbial species in the 
metagenome samples35.
Literature (Online-only Table 2) and 
NJS1634.
Manual collection of metabolic information 
from literature, and revision of NJS16 
(Methods).
Interaction network of microbial species/
host cells mediated by metabolic compounds, 
NJC19 (Online-only Tables 3–5 and the 
corresponding JSON files35).
Mouse microbiome and metabolome 
data4,37,38.
Extraction of taxonomic compositions and 
metabolite levels (see Technical Validation 
and Fig. 3 legend).
Taxonomic compositions35, and microbial 
producer and metabolite levels for NJC19 
validation (Fig. 3).
Table 1. Datasets used for the construction and validation of NJC19.
5Scientific Data |           (2020) 7:204  | https://doi.org/10.1038/s41597-020-0516-5
www.nature.com/scientificdatawww.nature.com/scientificdata/
the abundance increase/decrease of microbes associated with a particular metabolite in our network is consistent with 
the shift of the metabolite level across different experimental conditions. Regarding this analysis, three published mouse 
studies were found to provide the information of both microbial and metabolite levels in their collected samples: one 
Fig. 2 Microbial taxonomic composition and network structural properties of NJC19. (a) Fraction of microbial 
species in the network, which belong to each domain (left) or phylum (right). The right panel shows several 
phyla with the largest fractions in each domain. Both left and right panels show bacteria in blue, archaea in 
tan, and eukaryotes in green. (b,c) The vertical axis represents the distribution of the probability P(k) that a 
given microbial species imports (b) or exports (c) k metabolites on the horizontal axis. (d,e) The vertical axis 
represents the distribution of the probability P(k) that a given metabolite is imported (d) or exported (e) by k 
species on the horizontal axis.
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Fig. 3 Comparison of mouse microbiome and metabolome data based on NJC19. (a,b) In the left panels, the 
abundances of the propionate (a) and acetate (b) producers in NJC19 were obtained from cecal 16S rRNA 
gene sequence data35 in ref. 37 Cecal metabolite concentrations in the right panels were obtained from Fig. 3c 
of the same study. Mouse group I consists of mice six weeks after 10-day cefoperazone treatment on mouse 
group II, cefoperazone-naive mice. (c) In the left panel, the abundances of the butyrate producers in NJC19 
were obtained from fecal 16S rRNA gene sequence data35 in ref. 4 Cecal butyrate concentrations in the right 
panel were obtained from Fig. 2c of the same study. Although we used the fecal 16S rRNA gene sequence data 
for the left panel due to the limited data availability, fecal and cecal microbial compositions were found to 
strongly correlate in other samples from that study, allowing us to use the fecal sequence data as a proxy for 
the cecal ones. All mice were initially germ-free in the study. Mouse groups I to V comprise mice transplanted 
with an obese twin’s microbiota (Ob; group I), mice co-housed with Ob and Ln mice (group II; see next for the 
definition of Ln mice), mice transplanted with the lean co-twin’s microbiota (Ln; group III), Ob mice co-housed 
with Ln and germ-free mice (group IV), and Ln mice co-housed with Ob and germ-free mice (group V). (d–f) 
In the left panels, the abundances of the succinate (d,e) and isovalerate (f) producers in NJC19 were obtained 
from cecal 16S rRNA gene copy levels in Fig. 2a of ref. 38 We re-scaled succinate producers in (d) to the total 16S 
rRNA gene copy levels, because the corresponding succinate concentrations (d) were available per cecal dry 
weight (i.e., per cecal microbial load). Cecal and portal vein metabolite concentrations in the right panels were 
obtained from Fig. 2b and Supplementary Table 4 of the same study, respectively. Mouse groups ‘HF/HS’, ‘ZF/
HS’, and ‘Chow’ represent gnotobiotic mice on a high-fat/high-sucrose diet, a zero-fat/high-sucrose diet, and a 
chow diet, respectively. In (a–d), each error bar represents standard deviation across replicates. Error bars are 
missing for (e,f), as well as for the left panel in (d), and units are missing for the right panels in (e,f), because of 
the information unavailability from the data sources.
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study is for antibiotics (cefoperazone) treatment and recovery37, another is for fecal microbiota transplantation from 
twins discordant for obesity4, and the other for gnotobiotic mice with multiple diets38. From these studies, we consid-
ered only the cases with clear variations in the microbial and metabolite levels, which span at least 1.5-fold changes 
across different mouse groups for the metabolites and their microbial producers/consumers in NJC19. We further 
excluded host- and diet-derived metabolites, which may confound our analysis focusing on the effects of microbial 
metabolism. For all the resulting metabolites, Fig. 3 presents the levels of their microbial producers in NJC19 and those 
metabolite levels across the mouse groups with varying experimental conditions (Table 1). In Fig. 3, we did not con-
sider microbial consumers because they were relatively deficient in their abundance, less than a half of the producers in 
each case. Here, microbial producers of each metabolite from the gnotobiotic mouse study38 in Fig. 3 are defined as the 
microbial species that produce this metabolite in NJC19. However, for the other two studies in Fig. 3, the finest taxo-
nomic information is available at the genus level35, from the 16S rRNA gene sequence data processed by the Ribosomal 
Database Project Classifier in this analysis (RDP Naive Bayesian rRNA Classifier Version 2.11 with 16S rRNA training 
set 16)39. Therefore, for these two studies, microbial producers of a given metabolite are defined as the microbial genera, 
with each having the species whose majority (>50%) can produce that metabolite in NJC19. We also defined microbial 
consumers in a similar way, although they were excluded from Fig. 3 as discussed above.
Figure 3 indeed demonstrates that alternations in the producer and metabolite levels tend to agree with each 
other, with the overall 71.4% matches of their increasing or decreasing tendencies across the mouse groups. For 
example, the propionate producers in NJC19 decreased by 90.0% in the cecum after cefoperazone treatment and 
recovery, consistent with an 88.5% decrease in the cecal propionate concentration (Fig. 3a). Likewise, the acetate 
producers in NJC19 decreased by 64.5% at the same time, consistent with a 59.3% decrease in the cecal acetate 
concentration (Fig. 3b). In these examples, the total microbial loads remained similar during the experiments37, 
and thus the metabolite concentration changes here are not likely to be a mere consequence of the microbial load 
changes. To test the statistical significance of these correlations, we introduce quantities fij, gij, and fij’ for each pair 
of mouse groups i and j: fij (gij) denotes a fold change from group i to group j in the measured producer (metabo-
lite) abundance averaged over the replicates in the group i or j. fij’ denotes a group-i-to-j fold change in the average 
abundance of randomly-assigned producers, while the number of those randomly-assigned producers from all 
the data sources in Fig. 3 is maintained as the same as the number of the total observed producers. To assess the 
significance of the observed producer and metabolite correlations against a scenario that the producer informa-
tion in NJC19 may not be more correct than expected by chance, we computed the P value as the probability of 
satisfying fij’ ≥ fij (fij’ ≤ fij) for all (i, j)-pairs that have fij and gij with both ≥ 1 (≤1). Accordingly, our P value calcu-
lation reveals that the producers in NJC19 and the detected metabolic compounds are significantly correlated in 
Fig. 3, thereby supporting the validity of the microbe-compound associations in NJC19 (P = 0.02 for Fig. 3a,c–e, 
P < 10–4 for Fig. 3f, and P = 0.06 for Fig. 3b).
Code availability
Our Python code that converts the JSON format of NJC19 network data (NJC19_network.json35) to the format 
of Supplementary Table 1 can be downloaded from the Dryad Digital Repository35. For the taxonomic profiling 
of microbiome samples for the NJC19 construction, we used MetaPhlAn v2.0 with the “sensitive-local” mapping 
option and QIIME v1.8.0 with Greengenes v13_8_pp reference files30,31, as described above. The aforementioned 
cys file of NJC19 for network visualization was produced by Cytoscape v3.7.236.
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